+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Anaphylaxis Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Medication Type, Route of Administration, Allergy Type, and Distribution Channel

  • PDF Icon

    Report

  • 203 Pages
  • June 2021
  • Region: Global
  • The Insight Partners
  • ID: 5394044
UP TO OFF until Mar 15th 2023
Novel Drug Delivery Systems to Favor Anaphylaxis Treatment Market Growth During 2021-2028



According to the new research study on “Anaphylaxis Treatment Market Forecast to 2027 - COVID-19 Impact and Global Analysis - by Medication Type, Route of Administration, Allergy Type, and Distribution Channel,” the market is expected to reach US$ US$ 4,787.66 million in 2028 from US$ 2,664.66 million in 2021; it is estimated to grow at a CAGR of 8.7% from 2021 to 2028. The report highlights major market drivers and prominent companies along with their key developments in the market.



Novel drug delivery systems support improved drug potency and controlled drug release, along with imparting a sustained therapeutic effect for reliable safety. Many drugs have a maximum concentration range for maximum benefit, and concentrations above or below can be toxic or produce no medicinal use. Furthermore, various drug delivery and drug targeting systems are explained to have a capability of minimizing drug degradation as well as preventing harmful side effects. The intramuscular injection of epinephrine is normally underutilized when anaphylaxis occurs, mainly due to unavailability or unaffordability. Drugs provide the convenience of a wide range of pain-free multiple doses, particularly for children, if required, for outoof-hospital emergency treatment of anaphylaxis.



According to the paper published by Nova Southeastern University, recently, epinephrine can be administered sublingually by utilizing a novel fastodisintegrating tablet formulation. However, the relative sublingual bioavailability of epinephrine via tablet formulation is low. Therefore, this proposal aims to discuss more about tablets that will significantly enhance the sublingual epinephrine bioavailability.



Geographically, the anaphylaxis treatment market is segmented into North America, Europe, Asia Pacific (APAC), the Middle East and Africa (MEA), and South and Central America (SCAM). North America held the largest market share in 2020. In North America, the US holds the largest share of the North American anaphylaxis treatment market. The growth of the anaphylaxis treatment market in the US is determined due to factors such as easy access to the allergy medications, rising incidences of allergic reactions, and growing government policies to access epinephrine to school-going children. Also, the rising number of a product launch for generic version medicines is dominating the epinephrine market across the region.



The market in Canada and Mexico is expected to grow due to rising supply of generic version of anaphylaxis medicine by various market players. Also, rising incidences of anaphylaxis in these countries are likely to severe as the growth of the anaphylaxis treatment market during the forecast period.



Amneal Pharmaceuticals Inc; Bioprojet; Mylan N.V.; Adamis Pharmaceutical Corporation; Abbott; Pfizer Inc; Glaxosmithkline Plc; Merck And Co. Inc; Teva Pharmaceutical Industries Ltd; and ALK-ABELLó are among the leading companies operating in the anaphylaxis treatment market.



The report analyzes anaphylaxis treatment market based on following segments:


By Medication Type


  • Epinephrine
  • Antihistamines
  • Steroids
  • Beta-Agonist
  • Others

By Route of Administration


  • Oral
  • Parenteral
  • Others

By Allergy Type


  • Food Allergy
  • Medications
  • Insect Stings
  • Others

By Distribution Channel


  • Food Hospital Pharmacies
  • Retail Sales
  • Others

Anaphylaxis Treatment Market, by Geography


  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • France
  • Germany
  • UK
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific (APAC)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East and Africa (MEA)
  • Saudi Arabia
  • UAE
  • South Africa
  • Rest of Middle East and Africa
  • South and Central America (SCAM)
  • Brazil
  • Argentina
  • Rest of South and Central America


Reasons to Buy
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the anaphylaxis treatment market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global anaphylaxis treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Frequently Asked Questions about the Global Anaphylaxis Treatment Market

What is the estimated value of the Global Anaphylaxis Treatment Market?

The Global Anaphylaxis Treatment Market was estimated to be valued at $2664.66 Million in 2021.

What is the growth rate of the Global Anaphylaxis Treatment Market?

The growth rate of the Global Anaphylaxis Treatment Market is 8.7%, with an estimated value of $4787.66 Million by 2028.

What is the forecasted size of the Global Anaphylaxis Treatment Market?

The Global Anaphylaxis Treatment Market is estimated to be worth $4787.66 Million by 2028.

Who are the key companies in the Global Anaphylaxis Treatment Market?

Key companies in the Global Anaphylaxis Treatment Market include Amneal Pharmaceuticals Inc., Bioprojet, Mylan N.V., Adamis Pharmaceutical Corporation, Abbott, Pfizer Inc., Glaxosmithkline Plc.,, Merck And Co., Inc. and ALK.

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 The Publisher's Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Anaphylaxis Treatment Market - By Medication Type
1.3.2 Global Anaphylaxis Treatment Market - By Application
1.3.3 Global Anaphylaxis Treatment Market - By Allergy Type
1.3.4 Global Anaphylaxis Treatment Market - By End User
1.3.5 Global Anaphylaxis Treatment Market - By Geography
2. Anaphylaxis Treatment Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Anaphylaxis Treatment Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.2.2 Europe - PEST Analysis
4.2.3 Asia Pacific - PEST Analysis
4.2.4 Middle East and Africa (MEA) - PEST Analysis
4.2.5 South and Central America (SCAM) - PEST Analysis
4.3 Expert Opinions
5. Anaphylaxis Treatment Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Incidence of Anaphylaxis
5.1.2 Recent Approvals for Epinephrine
5.2 Market Restraints
5.2.1 Poor Access to Epinephrine Auto-Injectors in Low-Income Countries
5.3 Market Opportunities
5.3.1 Rise in Cases of Allergies Post Administration of COVID-19 Vaccines
5.4 Future Trends
5.4.1 Novel Drug Delivery Systems
5.5 Impact Analysis
6. Anaphylaxis Treatment Market - Global Analysis
6.1 Global Anaphylaxis Treatment Market Revenue Forecast and Analysis
6.2 Global Anaphylaxis Treatment Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Anaphylaxis Treatment Market Analysis - By Medication Type
7.1 Overview
7.2 Anaphylaxis Treatment Market Revenue Share, by Medication Type (2020 and 2028)
7.3 Epinephrine
7.3.1 Overview
7.3.2 Epinephrine: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Antihistamines
7.4.1 Overview
7.4.2 Antihistamines: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Steroids
7.5.1 Overview
7.5.2 Steroids: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
7.6 Beta-Agonist
7.6.1 Overview
7.6.2 Beta-Agonist: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
8. Anaphylaxis Treatment Market Analysis - By Route of Administration
8.1 Overview
8.2 Anaphylaxis Treatment Market Revenue Share, by Route of Administration (2020 and 2028)
8.3 Oral
8.3.1 Overview
8.3.2 Oral: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Parenteral
8.4.1 Overview
8.4.2 Parenteral: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
9. Anaphylaxis Treatment Market Analysis - By Allergy Type
9.1 Overview
9.2 Anaphylaxis Treatment Market Share, by Allergy Type, 2020 and 2028, (%)
9.3 Food Allergy
9.3.1 Overview
9.3.2 Food Allergy: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Medications
9.4.1 Overview
9.4.2 Medications: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Insect Stings
9.5.1 Overview
9.5.2 Insect Stings: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Million)
10. Anaphylaxis Treatment Market Analysis and Forecast - By Distribution Channel
10.1 Overview
10.2 Anaphylaxis Treatment Market, by Distribution Channel, 2020 and 2028 (%)
10.3 Retail Sales
10.3.1 Overview
10.3.2 Retail Sales: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Mn)
10.4 Hospital Pharmacies
10.4.1 Overview
10.4.2 Hospital Pharmacies: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Mn)
10.5 Others
10.5.1 Overview
10.5.2 Others: Anaphylaxis Treatment Market, Revenue and Forecast to 2028 (US$ Mn)
11. Global Anaphylaxis Treatment Market - Geographical Analysis
11.1 North America: Anaphylaxis Treatment Market
11.1.1 Overview
11.1.2 North America: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.1.3 North America: Anaphylaxis Treatment Market, by Medication Type, 2019-2028 (USD Million)
11.1.4 North America: Epinephrine Treatment Market by Route of Administration, 2019-2028 (USD Million)
11.1.5 North America: Others Treatment Market by Route of Administration, 2019-2028 (USD Million)
11.1.6 North America: Anaphylaxis Treatment Market, by Allergy Type, 2019-2028 (USD Million)
11.1.7 North America: Anaphylaxis Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
11.1.8 North America: Anaphylaxis Treatment Market, by Country, 2020 & 2028 (%)
11.1.8.1 US: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.1.8.1.1 US: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.1.8.1.2 US: Anaphylaxis Treatment Market, by Medication Type, 2019-2028 (USD Million)
11.1.8.1.3 US: Epinephrine Treatment Market by Route of Administration, 2019-2028 (USD Million)
11.1.8.1.4 US: Others Treatment Market by Route of Administration, 2019-2028 (USD Million)
11.1.8.1.5 US: Anaphylaxis Treatment Market, by Allergy Type, 2019-2028 (USD Million)
11.1.8.1.6 US: Anaphylaxis Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
11.1.8.2 Canada: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.1.8.2.1 Canada: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.1.8.2.2 Canada: Anaphylaxis Treatment Market, by Medication Type, 2019-2028 (USD Million)
11.1.8.2.3 Canada: Epinephrine Treatment Market, by Route of Administration, 2019-2028 (USD Million)
11.1.8.2.4 Canada: Others Treatment Market, by Route of Administration, 2019-2028 (USD Million)
11.1.8.2.5 Canada: Anaphylaxis Treatment Market, by Allergy Type, 2019-2028 (USD Million)
11.1.8.2.6 Canada: Anaphylaxis Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
11.1.8.3 Mexico: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.1.8.3.1 Mexico: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.1.8.3.2 Mexico: Anaphylaxis Treatment Market, by Medication Type, 2019-2028 (USD Million)
11.1.8.3.3 Mexico: Anaphylaxis Treatment Market, by Route of Administration, 2019-2028 (USD Million)
11.1.8.3.4 Mexico: Anaphylaxis Treatment Market, by Route of Administration, 2019-2028 (USD Million)
11.1.8.3.5 Mexico: Anaphylaxis Treatment Market, by Allergy Type, 2019-2028 (USD Million)
11.1.8.3.6 Mexico: Anaphylaxis Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
11.2 Europe: Anaphylaxis Treatment Market
11.2.1 Overview
11.2.2 Europe: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.2.3 Europe: Anaphylaxis Treatment Market, by Device, 2019-2028 (USD Million)
11.2.4 Europe: Epinephrine Treatment Market, by Route of Administration 2019-2028 (USD Million)
11.2.5 Europe: Others Treatment Market, by Route of Administration 2019-2028 (USD Million)
11.2.6 Europe: Anaphylaxis Treatment Market, by Allergy Type 2019-2028 (USD Million)
11.2.7 Europe: Anaphylaxis Treatment Market, by Distribution Channel 2019-2028 (USD Million)
11.2.8 Europe: Anaphylaxis Treatment Market, by Country, 2020 & 2028 (%)
11.2.8.1 Germany: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.2.8.1.1 Germany: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.2.8.1.2 Germany: Anaphylaxis Treatment Market, by Medication Type 2019-2028 (USD Million)
11.2.8.1.3 Germany: Epinephrine Treatment Market, by Route of Administration 2019-2028 (USD Million)
11.2.8.1.4 Germany: Others Treatment Market, by Route of Administration 2019-2028 (USD Million)
11.2.8.1.5 Germany: anaphylaxis treatment Market, by Allergy Type 2019-2028 (USD Million)
11.2.8.1.6 Germany: Anaphylaxis Treatment Market, by Distribution Channel 2019-2028 (USD Million)
11.2.8.2 UK: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.2.8.2.1 UK: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.2.8.2.2 UK: Anaphylaxis Treatment Market, Medication Type, 2019-2028 (USD Million)
11.2.8.2.3 UK: Epinephrine Treatment Market, by Route of Administration 2019-2028 (USD Million)
11.2.8.2.4 UK: Others Treatment Market, by Route of Administration 2019-2028 (USD Million)
11.2.8.2.5 UK: Anaphylaxis Treatment Market, by Allergy Type 2019-2028 (USD Million)
11.2.8.2.6 UK: Anaphylaxis Treatment Market, by Distribution Channel 2019-2028 (USD Million)
11.2.8.3 France: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.2.8.3.1 France: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.2.8.3.2 France: Anaphylaxis Treatment Market, by Medication Type, 2019-2028 (USD Million)
11.2.8.3.3 France: Epinephrine Treatment Market, by Route of Administration 2019-2028 (USD Million)
11.2.8.3.4 France: Others Treatment Market, by Route of Administration 2019-2028 (USD Million)
11.2.8.3.5 France: Anaphylaxis Treatment Market, by Allergy Type 2019-2028 (USD Million)
11.2.8.3.6 France: Anaphylaxis Treatment Market, by Distribution Channel 2019-2028 (USD Million)
11.2.8.4 Italy: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.2.8.4.1 Italy: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.2.8.4.2 Italy: Anaphylaxis Treatment Market, by Medication Type, 2019-2028 (USD Million)
11.2.8.4.3 Italy: Epinephrine Treatment Market, by Route of Administration, 2019-2028 (USD Million)
11.2.8.4.4 Italy: Others Treatment Market, by Route of Administration, 2019-2028 (USD Million)
11.2.8.4.5 Italy: Anaphylaxis Treatment Market, by Allergy Type, 2019-2028 (USD Million)
11.2.8.4.6 Italy: Anaphylaxis Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
11.2.8.5 Spain: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.2.8.5.1 Spain: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.2.8.5.2 Spain: Anaphylaxis Treatment Market, by Medication Type, 2019-2028 (USD Million)
11.2.8.5.3 Spain: Epinephrine Treatment Market, by Route of Administration, 2019-2028 (USD Million)
11.2.8.5.4 Spain: Others Treatment Market, by Route of Administration, 2019-2028 (USD Million)
11.2.8.5.5 Spain: Anaphylaxis Treatment Market, by Allergy Type, 2019-2028 (USD Million)
11.2.8.5.6 Spain: Anaphylaxis Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
11.2.8.6 Rest of Europe: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.2.8.6.1 Rest of Europe: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.2.8.6.2 Rest of Europe: Anaphylaxis Treatment Market, by Medication Type, 2019-2028 (USD Million)
11.2.8.6.3 Rest of Europe: Epinephrine Treatment Market, by Route of Administration, 2019-2028 (USD Million)
11.2.8.6.4 Rest of Europe: Others Treatment Market, by Route of Administration, 2019-2028 (USD Million)
11.2.8.6.5 Rest of Europe: Anaphylaxis Treatment Market, by Allergy Type, 2019-2028 (USD Million)
11.2.8.6.6 Rest of Europe: Anaphylaxis Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
11.3 Asia Pacific: Anaphylaxis Treatment Market
11.3.1 Overview
11.3.2 Asia Pacific: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.3.3 Asia Pacific: Anaphylaxis Treatment Market, by Medication Type, 2019-2028 (USD Million)
11.3.4 Asia Pacific: Epinephrine Treatment Market, by Route of Administration, 2019-2028 (USD Million)
11.3.5 Asia Pacific: Others Treatment Market, by Route of Administration, 2019-2028 (USD Million)
11.3.6 Asia Pacific: Anaphylaxis Treatment Market, by Allergy Type, 2019-2028 (USD Million)
11.3.7 Asia Pacific: Anaphylaxis Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
11.3.8 Asia Pacific: Anaphylaxis Treatment Market, by Country, 2020 & 2028 (%)
11.3.8.1 Japan: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.3.8.1.1 Japan: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.3.8.1.2 Japan: Anaphylaxis Treatment Market, by Medication Type, 2019-2028 (USD Million)
11.3.8.1.3 Japan: Epinephrine Treatment Market, by Route of Administration, 2019-2028 (USD Million)
11.3.8.1.4 Japan: Others Treatment Market, by Route of Administration, 2019-2028 (USD Million)
11.3.8.1.5 Japan: Anaphylaxis Treatment Market, by Allergy Type, 2019-2028 (USD Million)
11.3.8.1.6 Japan: Anaphylaxis Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
11.3.8.2 China: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.3.8.2.1 China: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.3.8.2.2 China: Anaphylaxis Treatment Market, by Medication Type, 2019-2028 (USD Million)
11.3.8.2.3 China: Epinephrine Treatment Market, by Route of Administration, 2019-2028 (USD Million)
11.3.8.2.4 China: Others Treatment Market, by Route of Administration, 2019-2028 (USD Million)
11.3.8.2.5 China: Anaphylaxis Treatment Market, by Allergy Type, 2019-2028 (USD Million)
11.3.8.2.6 China: Anaphylaxis Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
11.3.8.3 India: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.3.8.3.1 India: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.3.8.3.2 India: Anaphylaxis Treatment Market, by Medication Type, 2019-2028 (USD Million)
11.3.8.3.3 India: Epinephrine Treatment Market, by Route of Administration, 2019-2028 (USD Million)
11.3.8.3.4 India: Others Treatment Market, by Route of Administration, 2019-2028 (USD Million)
11.3.8.3.5 India: Anaphylaxis Treatment Market, by Allergy Type, 2019-2028 (USD Million)
11.3.8.3.6 India: Anaphylaxis Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
11.3.8.4 South Korea: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.3.8.4.1 South Korea: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.3.8.4.2 South Korea: Anaphylaxis Treatment Market, by Medication Type, 2019-2028 (USD Million)
11.3.8.4.3 South Korea: Epinephrine Treatment Market, by Route of Administration, 2019-2028 (USD Million)
11.3.8.4.4 South Korea: Others Treatment Market, by Route of Administration, 2019-2028 (USD Million)
11.3.8.4.5 South Korea: Anaphylaxis Treatment Market, by Allergy Type, 2019-2028 (USD Million)
11.3.8.4.6 South Korea: Anaphylaxis Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
11.3.8.5 Australia: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.3.8.5.1 Australia: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.3.8.5.2 Australia: Anaphylaxis Treatment Market, by Medication Type, 2019-2028 (USD Million)
11.3.8.5.3 Australia: Epinephrine Treatment Market, by Route of Administration, 2019-2028 (USD Million)
11.3.8.5.4 Australia: Others Treatment Market, by Route of Administration, 2019-2028 (USD Million)
11.3.8.5.5 Australia: Anaphylaxis Treatment Market, by Allergy Type, 2019-2028 (USD Million)
11.3.8.5.6 Australia: Anaphylaxis Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
11.3.8.6 Rest of Asia Pacific: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.3.8.6.1 Rest of Asia Pacific: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.3.8.6.2 Rest of Asia Pacific: Anaphylaxis Treatment Market, by Medication Type, 2019-2028 (USD Million)
11.3.8.6.3 Rest of Asia Pacific: Epinephrine Treatment Market, by Route of Administration, 2019-2028 (USD Million)
11.3.8.6.4 Rest of Asia Pacific: Others Treatment Market, by Route of Administration, 2019-2028 (USD Million)
11.3.8.6.5 Rest of Asia Pacific: Anaphylaxis Treatment Market, by Allergy Type, 2019-2028 (USD Million)
11.3.8.6.6 Rest of Asia Pacific: Anaphylaxis Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
11.4 Middle East & Africa: Anaphylaxis Treatment Market
11.4.1 Overview
11.4.2 Middle East & Africa: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.4.3 Middle East & Africa: Anaphylaxis Treatment Market, by Medication Type, 2019-2028 (USD Million)
11.4.4 Middle East & Africa: Epinephrine Treatment Market by Route of Administration, 2019-2028 (USD Million)
11.4.5 Middle East & Africa: Others Treatment Market by Route of Administration, 2019-2028 (USD Million)
11.4.6 Middle East & Africa: Anaphylaxis Treatment Market, by Allergy Type, 2019-2028 (USD Million)
11.4.7 Middle East & Africa: Anaphylaxis Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
11.4.8 Middle East and Africa: Anaphylaxis Treatment Market, by Country, 2020 & 2028 (%)
11.4.8.1 Saudi Arabia: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.4.8.1.1 Saudi Arabia: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.4.8.1.2 Saudi Arabia: Anaphylaxis Treatment Market, by Medication Type, 2019-2028 (USD Million)
11.4.8.1.3 Saudi Arabia: Epinephrine Treatment Market by Route of Administration, 2019-2028 (USD Million)
11.4.8.1.4 Saudi Arabia: Others Treatment Market by Route of Administration, 2019-2028 (USD Million)
11.4.8.1.5 Saudi Arabia: Anaphylaxis Treatment Market, by Allergy Type, 2019-2028 (USD Million)
11.4.8.1.6 Saudi Arabia: Anaphylaxis Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
11.4.8.2 UAE: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.4.8.2.1 UAE: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.4.8.2.2 UAE: Anaphylaxis Treatment Market, by Medication Type, 2019-2028 (USD Million)
11.4.8.2.3 UAE: Epinephrine Treatment Market by Route of Administration, 2019-2028 (USD Million)
11.4.8.2.4 UAE: Others Treatment Market by Route of Administration, 2019-2028 (USD Million)
11.4.8.2.5 UAE: Anaphylaxis Treatment Market, by Allergy Type, 2019-2028 (USD Million)
11.4.8.2.6 UAE: Anaphylaxis Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
11.4.8.3 South Africa: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.4.8.3.1 South Africa: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.4.8.3.2 South Africa: Anaphylaxis Treatment Market, by Medication Type, 2019-2028 (USD Million)
11.4.8.3.3 South Africa: Epinephrine Treatment Market by Route of Administration, 2019-2028 (USD Million)
11.4.8.3.4 South Africa: Others Treatment Market by Route of Administration, 2019-2028 (USD Million)
11.4.8.3.5 South Africa: Anaphylaxis Treatment Market, by Allergy Type, 2019-2028 (USD Million)
11.4.8.3.6 South Africa: Anaphylaxis Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
11.4.8.4 Rest of Middle East and Africa: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.4.8.4.1 Rest of Middle East and Africa: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.4.8.4.2 Rest of Middle East and Africa: Anaphylaxis Treatment Market, by Medication Type, 2019-2028 (USD Million)
11.4.8.4.3 Rest of Middle East and Africa: Epinephrine Treatment Market by Route of Administration, 2019-2028 (USD Million)
11.4.8.4.4 Rest of Middle East and Africa: Others Treatment Market by Route of Administration, 2019-2028 (USD Million)
11.4.8.4.5 Rest of Middle East and Africa: Anaphylaxis Treatment Market, by Allergy Type, 2019-2028 (USD Million)
11.4.8.4.6 Rest of Middle East and Africa: Anaphylaxis Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
11.5 South and Central America: Anaphylaxis Treatment Market
11.5.1 Overview
11.5.2 South and Central America: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)
11.5.3 South and Central America: Anaphylaxis Treatment Market, by Medication Type, 2019 -2028 (USD Million)
11.5.4 South and Central America: Epinephrine Treatment Market by Route of Administration, 2019-2028 (USD Million)
11.5.5 South and Central America: Others Treatment Market by Route of Administration, 2019-2028 (USD Million)
11.5.6 South and Central America: Anaphylaxis Treatment Market, by Allergy Type, 2019 -2028 (USD Million)
11.5.7 South and Central America: Anaphylaxis Treatment Market, by Distribution Channel, 2019 -2028 (USD Million)
11.5.8 South and Central America: Anaphylaxis Treatment Market Share by Country - 2020 & 2028, (%)
11.5.8.1 Brazil: Anaphylaxis Treatment Market- Revenue and Forecasts to 2028 (USD Million)
11.5.8.1.1 Brazil: Anaphylaxis Treatment Market- Revenue and Forecasts to 2028 (USD Million)
11.5.8.1.2 Brazil: Anaphylaxis Treatment Market, by Medication Type, 2019 -2028 (USD Million)
11.5.8.1.3 Brazil: Epinephrine Treatment Market by Route of Administration, 2019-2028 (USD Million)
11.5.8.1.4 Brazil: Others Treatment Market by Route of Administration, 2019-2028 (USD Million)
11.5.8.1.5 Brazil: Anaphylaxis Treatment Market, by Allergy Type, 2019-2028 (USD Million)
11.5.8.1.6 Brazil: Anaphylaxis Treatment Market, by Distribution Channel, 2019-2028 (USD Million)
11.5.8.2 Argentina: Anaphylaxis Treatment Market- Revenue and Forecasts to 2028 (USD Million)
11.5.8.2.1 Argentina: Anaphylaxis Treatment Market- Revenue and Forecasts to 2028 (USD Million)
11.5.8.2.2 Argentina: Anaphylaxis Treatment Market, by Medication Type, 2019 -2028 (USD Million)
11.5.8.2.3 Argentina: Epinephrine Treatment Market by Route of Administration, 2019-2028 (USD Million)
11.5.8.2.4 Argentina: Others Treatment Market by Route of Administration, 2019-2028 (USD Million)
11.5.8.2.5 Argentina: Anaphylaxis Treatment Market, by Allergy Type, 2019 -2028 (USD Million)
11.5.8.2.6 Argentina: Anaphylaxis Treatment Market, by Distribution Channel, 2019 -2028 (USD Million)
11.5.8.3 Rest of South and Central America: Anaphylaxis Treatment Market- Revenue and Forecasts to 2028 (USD Million)
11.5.8.3.1 Rest of South and Central America: Anaphylaxis Treatment Market- Revenue and Forecasts to 2028 (USD Million)
11.5.8.3.2 Rest of South and Central America: Anaphylaxis Treatment Market, by Medication Type, 2019 -2028 (USD Million)
11.5.8.3.3 Rest of South and Central America: Epinephrine Treatment Market by Route of Administration, 2019-2028 (USD Million)
11.5.8.3.4 Rest of South and Central America: Others Treatment Market by Route of Administration, 2019-2028 (USD Million)
11.5.8.3.5 Rest of South and Central America: Anaphylaxis Treatment Market, by Allergy Type, 2018-2027 (USD Million)
11.5.8.3.6 Rest of South and Central America: Anaphylaxis Treatment Market, by Distribution Channel, 2018-2027 (USD Million)
12. Impact Of COVID-19 Pandemic on Global Anaphylaxis Treatment Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
12.2 Europe: Impact Assessment of COVID-19 Pandemic
12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
12.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
12.5 South and Central America: Impact Assessment of COVID-19 Pandemic
13. Anaphylaxis Treatment Market-Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. Company Profiles
14.1 Abbott
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Adamis Pharmaceuticals Corporation
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 ALK-Abelló A/S
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Amneal Pharmaceuticals, Inc.
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 BIOPROJET
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 GlaxoSmithKline plc.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Merck & Co., Inc.
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 MYLAN N.V.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Pfizer Inc.
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 TEVA PHARMACEUTICAL INDUSTRIES LTD
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About the Publisher
15.2 Glossary of Terms, Anaphylaxis Treatment Market

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Amneal Pharmaceuticals Inc.
  • Bioprojet
  • Mylan N.V.
  • Adamis Pharmaceutical Corporation
  • Abbott
  • Pfizer Inc.
  • Glaxosmithkline Plc.,
  • Merck And Co., Inc.
  • Teva Pharmaceutical Industries Ltd.
  • ALK-Abelló